Literature DB >> 2960374

The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat.

G M McCreanor1, D A Bender.   

Abstract

1. The metabolic fate of high dietary intakes of nicotinamide, nicotinic acid and tryptophan, and of acute doses of nicotinamide and nicotinic acid, has been studied in the rat. A new high-pressure liquid chromatography method for measurement of the principal urinary metabolites of niacin is described. 2. Administration to rats of a single oral dose of nicotinamide or nicotinic acid (up to 100 mg/kg body-weight), or maintenance for 3 weeks on diets providing 150 mg nicotinamide or nicotinic acid/kg diet, resulted in only a small increase in the liver content of nicotinamide nucleotide coenzymes (NAD and NADP). The quantitative metabolism of nicotinamide and nicotinic acid differed, suggesting that intestinal bacterial deamidation is not the major fate of nicotinamide. 3. A high dietary intake of tryptophan (5.9 g/kg diet) led to a considerable increase in liver NAD(P) and also in urinary excretion of niacin metabolites. The results suggest that, as indicated by enzyme kinetic studies (Bender et al. 1982), the utilization of nicotinamide and nicotinic acid for nucleotide synthesis is limited, while there is little or no limitation of NAD(P) synthesis from the tryptophan metabolite quinolinic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2960374     DOI: 10.1079/bjn19860138

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  10 in total

1.  Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Lambertus A Peletier; Rasmus Jansson-Löfmark; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-04       Impact factor: 2.745

Review 2.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.

Authors:  Ruben Nogueiras; Kirk M Habegger; Nilika Chaudhary; Brian Finan; Alexander S Banks; Marcelo O Dietrich; Tamas L Horvath; David A Sinclair; Paul T Pfluger; Matthias H Tschöp
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 3.  Modulating NAD+ metabolism, from bench to bedside.

Authors:  Elena Katsyuba; Johan Auwerx
Journal:  EMBO J       Date:  2017-08-07       Impact factor: 11.598

4.  Lesch-Nyhan syndrome and its pathogenesis: normal nicotinamide-adenine dinucleotide but reduced ATP concentrations that correlate with reduced poly(ADP-ribose) synthetase activity in HPRT-deficient lymphoblasts.

Authors:  G M McCreanor; R A Harkness
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  Sirtuins as novel players in the pathogenesis of diabetes mellitus.

Authors:  Kultigin Turkmen; Ali Karagoz; Adem Kucuk
Journal:  World J Diabetes       Date:  2014-12-15

6.  Biocidal action of chlorhexidine is annulled by nicotinic acid.

Authors:  H Baker; O Frank; B DeAngelis; E R Baker
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 8.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.

Authors:  Abdulla A-B Badawy
Journal:  Int J Tryptophan Res       Date:  2017-03-15

Review 9.  Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.

Authors:  Abdulla A-B Badawy
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

Review 10.  Oncology Therapeutics Targeting the Metabolism of Amino Acids.

Authors:  Nefertiti Muhammad; Hyun Min Lee; Jiyeon Kim
Journal:  Cells       Date:  2020-08-15       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.